Elanco Announces Agreement to Acquire Aratana Therapeutics; Completes Oncology Development Agreement with VetDC, Creates Specialty Veterinary Business Focus

Stock Information for Aratana Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Aratana Therapeutics Inc.

Aratana Therapeutics' Stockholders Adopt Merger Agreement with Elanco Animal Health
Rigrodsky & Long, P.A. Files Class Action Suit Against Aratana Therapeutics, Inc.
CureVac Welcomes Two Members to its Supervisory Board
Aratana Therapeutics Granted FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) 10 mL Vial
Aratana Therapeutics Reports Voting Results from 2019 Annual Meeting of Stockholders
AMBR, PETX Shareholder Class Actions: Halper Sadeh LLP Announces Shareholder Class Action Lawsuits Against Amber Road, Inc. and Aratana Therapeutics, Inc. - AMBR, PETX
CORRECTION - Rigrodsky & Long, P.A. Files Class Action Suit Against Aratana Therapeutics, Inc.
Rigrodsky & Long, P.A. Files Class Action Suit Against Aratana Therapeutics, Inc.

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.